10:26 AM EST - Therma Bright Inc. : Announced that its AI-powered Digital Cough Technology (DCT), with development partner AI4LYF, is currently being considered as a partner technology for a new innovative, disruptive chronic cough drug US-based clinical trial. Therma Bright Inc.
shares V.THRM are trading unchanged at $0.09.
